Catheter Precision announces that its VIVO 3D mapping system has been granted national reimbursement in the UK after inclusion in the High-Coast Tariff Excluded Devices. VIVO enables physicians to identify the origin of ventricular arrhythmias pre-procedure, streamlining workflow and reducing procedure time.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on VTAK: